Phytopharm PLC (PYM.L) Stopping R&D Spending, Cutting Headcount
3/26/2013 7:36:05 AM
More...
|
Phytopharm PLC (PYM.L) Hit by Failure of Parkinson's Drug
2/19/2013 7:57:52 AM
More...
|
Phytopharm PLC (PYM.L)'s Cogane(TM) - US FDA Grant Orphan Drug Status for Treatment of ALS
7/28/2011 10:30:28 AM
More...
|
Phytopharm PLC (PYM.L) Interim Results for the Six Months Ended 31 March 2011
5/26/2011 9:56:51 AM
More...
|
Phytopharm PLC (PYM.L) Preliminary Results for theYear Ended 30 September 2010
11/30/2010 10:10:01 AM
More...
|
Phytopharm PLC (PYM.L) Announces Commencement of Phase II Study of Cogane(TM) in Patients with Parkinson's Disease
11/17/2010 2:18:25 PM
More...
|
Phytopharm PLC (PYM.L) to Present Data on Cogane at Upcoming Scientific Conferences
9/29/2010 1:17:14 PM
More...
|
Phytopharm PLC (PYM.L) Interim Management Statement
8/18/2010 11:11:41 AM
More...
|
Tim Sharpington New CEO for Phytopharm PLC (PYM.L)
6/21/2010 7:03:09 AM
More...
|
Phytopharm PLC (PYM.L): Interim Results for the Six Months Ended 31 March 2010
5/24/2010 11:06:42 AM
More...
|
|